1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Brain Tumor Diagnosis & Treatment Market, by Treatment
6.1. Introduction
6.2. Chemotherapy
6.3. Immunotherapy
6.4. Radiation Therapy
6.5. Radiosurgery
6.6. Surgery
6.7. Targeted Drug Therapy

7. Brain Tumor Diagnosis & Treatment Market, by Diagnosis
7.1. Introduction
7.2. CT Scan
7.3. EEG
7.4. Molecular Testing
7.5. MRI
7.6. PET-CT Scan

8. Brain Tumor Diagnosis & Treatment Market, by Type
8.1. Introduction
8.2. Primary Brain Tumor
8.3. Secondary Brain Tumor

9. California Brain Tumor Diagnosis & Treatment Market

10. Florida Brain Tumor Diagnosis & Treatment Market

11. Illinois Brain Tumor Diagnosis & Treatment Market

12. New York Brain Tumor Diagnosis & Treatment Market

13. Ohio Brain Tumor Diagnosis & Treatment Market

14. Pennsylvania Brain Tumor Diagnosis & Treatment Market

15. Texas Brain Tumor Diagnosis & Treatment Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Amgen Inc.
17.2. AstraZeneca PLC
17.3. Canon Medical Systems Corporation
17.4. Carestream Health, Inc.
17.5. Eisai Co., Ltd.
17.6. Elekta AB
17.7. GE Healthcare
17.8. Hitachi Medical Systems
17.9. Koninklijke Philips N.V.
17.10. Merck & Co., Inc.
17.11. Pfizer Inc.
17.12. Shimadzu Corporation
17.13. Siemens Healthineers AG
17.14. Varian Medical Systems, Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2027
FIGURE 6. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIATION THERAPY, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIOSURGERY, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIOSURGERY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TARGETED DRUG THERAPY, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TARGETED DRUG THERAPY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2020 VS 2027 (%)
FIGURE 19. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2020 VS 2027 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2027
FIGURE 21. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CT SCAN, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CT SCAN, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY EEG, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY EEG, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MOLECULAR TESTING, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MOLECULAR TESTING, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MRI, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MRI, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PET-CT SCAN, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PET-CT SCAN, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 32. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2027
FIGURE 34. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY BRAIN TUMOR, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY BRAIN TUMOR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY BRAIN TUMOR, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY BRAIN TUMOR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 39. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 40. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIOSURGERY, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TARGETED DRUG THERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CT SCAN, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY EEG, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MOLECULAR TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MRI, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PET-CT SCAN, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY BRAIN TUMOR, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY BRAIN TUMOR, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: SCORES
TABLE 20. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: RANKING
TABLE 23. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

Amgen Inc.
AstraZeneca PLC
Canon Medical Systems Corporation
Carestream Health, Inc.
Eisai Co., Ltd.
Elekta AB
GE Healthcare
Hitachi Medical Systems
Koninklijke Philips N.V.
Merck & Co., Inc.
Pfizer Inc.
Shimadzu Corporation
Siemens Healthineers AG
Varian Medical Systems, Inc.